Tag:
Canal+
Ghost Bites
Ghost Bites (Aspen | ASP Isotopes | Boxer | Calgro M3 | Canal+ and MultiChoice)
Boxer's underlying story is good, but the IPO ruined profit growth. Canal+ will inward list on the JSE after the MultiChoice deal. Calgro M3's earnings fell this period based on infrastructure timing. ASP Isotopes locked in their biggest ever supply deal. Aspen is thrilled that Mounjaro can be prescribed for obesity in SA.